applying molecular understanding of dlbcl to management strategies
Published 4 years ago • 52 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
1:52
an insight into the optimal management of patients with dlbcl
-
7:16
changes in the classification of dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
8:01
novel diagnostics & biomarkers for dlbcl and ctcl
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
1:05
identifying high-risk dlbcl and optimizing treatment for these patients
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
1:31:43
ta7 usmle step 1 : leukemia & lymphoma
-
30:35
the genome of diffuse large b-cell lymphoma
-
4:16
slurred speech and difficulty walking, worse over 6 months
-
12:35
episode 1: role of quantitative radionuclide imaging in cardiac amyloidosis
-
1:02
the changing standard of care in dlbcl
-
2:19
italian perspective: managing dlbcl
-
0:44
clinical efficacy and safety of ct-p10 in patients with dlbcl
-
2:14
how to define and treat high-risk lymphoma
-
1:34
molecular-guided treatment of b-cell lymphomas
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
1:04
ft516: a novel nk cell therapy targeting b-cell lymphoma
-
1:46
ivlbcl: a retrospective study
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
7:18
precision epigenetic therapy for b-cell lymphoma
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl